John Rothman
Patrimonio netto: 14 470 $ in data 30/04/2025
Patrimonio netto: 14 470 $ in data 30/04/2025
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RIZE ONCOLOGY INC. 1,32% | 06/01/2025 | 1.000.000 ( 1,32% ) | 14 470 $ | 30/04/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| RIZE ONCOLOGY INC. | Direttore Tecnico/Scientifico/R&S | 09/01/2025 |
| Società | Posizione | Fine |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/02/2022 |
| RACURA ONCOLOGY LTD | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
| AYALA PHARMACEUTICALS, INC. | Direttore operativo | 09/12/2011 |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale